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OBJECTIVES We examined whether preinterventional arterial remodeling influenced the interventional
results after stenting.
BACKGROUND Arterial remodeling is seen in atherosclerotic lesions, and it may play an important role in the
early stage of atherosclerosis.
METHODS We examined 113 lesions that underwent elective stenting using tubular slotted stents under
intravascular ultrasound guidance. The lesions were divided into three groups—adequate,
intermediate and inadequate remodeling group—according to preinterventional arterial
remodeling. The patients were subjected to coronary angiography and intravascular ultra-
sound evaluation on average 6.4 months after stenting.
RESULTS At baseline and immediately after stenting, there were no differences in quantitative
angiographic analysis among remodeling groups. However, the plaque cross-sectional area
(CSA) in the minimal lumen CSA at preintervention and intimal hyperplasia CSA at
follow-up were significantly larger in the adequate remodeling group than in the inadequate
remodeling group. The restenosis rate of stenting for the lesions with inadequate arterial
remodeling was very low (9.4%). A significant positive correlation was found between
preinterventional plaque CSA and intimal hyperplasia CSA at follow-up (r 5 0.47, p ,
0.0001). Moreover, remodeling index significantly correlated with relative intimal hyperplasia
CSA (r 5 0.28, p , 0.01).
CONCLUSIONS Preinterventional arterial remodeling influenced the development of intimal hyperplasia after
stenting. (J Am Coll Cardiol 2001;37:70–5) © 2001 by the American College of Cardiology
Recently, there has been an increase in the number of
coronary angioplasties (1). Use of the Palmaz-Schatz stents
has contributed to the reduction of in-hospital complica-
tions and the incidence of restenosis after catheter interven-
tion, compared with conventional balloon angioplasty (2,3).
The widespread use of these stents has not only improved
the clinical outcomes of coronary angioplasty but has also
reduced the costs associated with readmission for repeat
revascularization (1). However, in-stent restenosis, which
occurs in 20% to 30% of the lesions, still remains as the most
important problem (4,5).
Recent studies have revealed that vascular remodeling
may play an important role in the early stage of atheroscle-
rosis. Compensatory enlargement of the coronary artery
might delay the progression of lumen stenosis induced by
the expanding atheromatous plaque (6–9). In contrast,
inadequate compensatory enlargement results in relative
vessel constriction at the lesion site, which might be an
important contributing factor for the development of lumi-
nal narrowing along with plaque proliferation (10,11).
Thus, we hypothesized that interventional procedures on
the atherosclerotic lesions with different types of arterial
remodeling might lead to different short- and long-term
outcomes and that the suitable procedures for atheroscle-
rotic lesions with adequate arterial remodeling might be
different from those with inadequate arterial remodeling.
However, there is little information about the relation
between arterial remodeling and interventional results. The
purpose of this study was to examine whether the degree of
preinterventional arterial remodeling influenced the devel-
opment of neointimal hyperplasia after stenting.
METHODS
Patient population. From October 1996 through October
1998, we screened for inclusion in this study 210 consecu-
tive patients with 231 lesions who underwent elective
stenting using tubular slotted stents (either a Palmaz-Schatz
stent or a Multi-Link stent) for native coronary artery
stenosis at the Nagoya Daini Red Cross Hospital. The
lesions were excluded when 1) intimal calcification at the
target lesion was so severe that it precluded accurate
quantification of intravascular ultrasound (IVUS) imaging
(10 lesions), 2) IVUS study of the target lesion and reference
segments could not be performed before the subsequent
intervention (15 lesions), 3) pretreatment with an athero-
ablative device was performed before stenting (36 lesions),
4) there were major side branches between the proximal and
distal reference segments (15 lesions), 5) distinct dissection
was made at the stent edge after stenting (4 lesions), and 6)
multiple stents were implanted (27 lesions). When multiple
lesions existed, we included only the lesion that was treated
first (11 lesions were excluded). Therefore, we selected 113
patients who had undergone stenting under IVUS guidance.
There were 88 men and 25 women, and their mean age was
62.9 6 8.3 years. These patients were subjected to follow-up
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coronary angiography and IVUS study 4 to 10 months
(mean of 6.4 6 1.4 months) after stenting. Data on risk
factors for coronary artery disease were obtained from
clinical records at the time of stenting. Diabetes mellitus
(medication-dependent only), hypertension (medication-
dependent only) and hyperlipidemia (medication-
dependent or serum total cholesterol $240 mg) were all
examined. As for the location of the target lesion, the left
anterior descending artery, the left circumflex artery and
the right coronary artery were involved in 61, 10, and
42 instances, respectively. Seven stents were placed in
restenotic lesions. The Palmaz-Schatz stent was used for 58
lesions, and the Multi-Link stent was used for 55 lesions.
Study protocol was approved by the Ethics Committee of
Nagoya Daini Red Cross Hospital, and written informed
consent was obtained from all patients.
Angiography and analysis. Initial and follow-up angio-
grams were performed in the same angiographic projections
using either a 6F diagnostic or 8F guiding catheter. Isosor-
bide dinitrate (5 mg) was administered by intracoronary
injection before each study. An independent investigator
blinded to the results of IVUS analysis performed quanti-
tative coronary angiography (QCA) analysis using the
Coronary Measurement System (MEDIS, Leiden, The
Netherlands). Reference diameter, minimal luminal diam-
eter and diameter stenosis at end-diastole before and im-
mediately after stenting (after the last adjunctive balloon
inflation) and at follow-up were calculated on the computer
screen with the use of the view that showed the most severe
luminal narrowing, using the guiding catheter for magnifi-
cation calibration reference. Angiographic restenosis was
defined as $50% diameter stenosis at follow-up.
IVUS imaging. The IVUS studies were performed before
and just after stenting, and at follow-up, using a 30-MHz
2.9F or 3.2F monorail intracoronary ultrasound catheter
(Cardiovascular Imaging Systems, Sunnyvale, California).
After diagnostic coronary angiography and before any in-
tervention, a 0.014-in. (0.0356-cm) coronary guide wire was
introduced into the target coronary artery that would
undergo subsequent stenting. To avoid spasm and to obtain
optimal vasodilatation, 5 mg of isosorbide dinitrate was
administered before insertion of the IVUS catheter through
a coronary guiding catheter over the guide wire. After the
IVUS catheter was advanced more than 10 mm beyond the
target lesion, a motorized auto pullback was performed at
0.5 mm/s to the aorto-ostimal junction under fluoroscopic
guidance. Immediately after stenting, and at follow-up,
IVUS studies were performed using the same methods
before any subsequent intervention for restenosis. All ultra-
sound images were recorded continuously on S-VHS vid-
eotape for off-line analysis.
IVUS analysis. Measurements of IVUS images were per-
formed using a commercially available software program
(TapeMeasure, Indec Systems, Capitola, California). In the
end-diastolic frames, we measured cross-sectional area
(CSA) within the external elastic membrane (EEM) and
lumen CSA at the lesion site and at the proximal and distal
reference sites. Plaque CSA was calculated as the EEM
CSA minus the lumen CSA. Plaque index was defined as
(the plaque CSA/the EEM CSA) 3 100. When the IVUS
catheter filled up the lumen owing to severe atherosclerosis,
the lumen CSA was assumed to be equal to the size of the
catheter. From the distal edge of stent to the proximal edge,
image slices of 3 mm each were taken into the analysis
system at follow-up, and the stent CSA and the lumen CSA
were measured. The intimal hyperplasia CSA presented
within the stent was calculated as the stent CSA minus the
lumen CSA. Relative intimal hyperplasia CSA was calcu-
lated as (the intimal hyperplasia CSA/the stent CSA) 3
100.
The lesion site was defined as the segment having the
smallest lumen CSA according to IVUS study, and $50%
diameter stenosis as assessed by QCA. All lesions under-
went subsequent coronary stenting. The proximal and distal
reference sites were defined according to previous reports
(11,12).
Adequate compensatory arterial remodeling was defined
as an EEM CSA at the lesion site that was larger than that
at the proximal reference site, and inadequate compensatory
arterial remodeling was defined as an EEM CSA at the
lesion site that was smaller than that at the distal reference
site. Intermediate arterial remodeling was defined as an
EEM CSA at the lesion site that was intermediate between
the proximal and distal reference sites. Remodeling index
was also defined as follows: the target lesion EEM CSA
divided by the average of the proximal and distal reference
EEM CSA.
Statistical analysis. Data were expressed as mean values 6
SD or percent. Differences among the examined groups
were tested for significance by analysis of variance. When an
overall difference was noted, the Fisher’s multiple range test
was applied for the pairwise comparisons. The chi-square
test was used across three groups for comparing categorical
variables. All analyses were performed with a StatView
statistical program (Version 5.0, SAS Institute, Cary, North
Carolina). The differences were considered significant when
p values were ,0.05.
RESULTS
Among all coronary arteries in which stent implantation had
been performed, 52 (46%) coronary arteries showed ade-
quate compensatory arterial remodeling, 32 (28%) coronary
Abbreviations and Acronyms
CSA 5 cross-sectional area
EEM 5 external elastic membrane
IVUS 5 intravascular ultrasound
QCA 5 quantitative coronary angiography
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arteries showed inadequate arterial remodeling, and 29
(26%) showed intermediate arterial remodeling.
Clinical characteristics and angiographic results. Clinical
lesions, and implanted stent characteristics are shown in
Table 1. The lesions treated by stent were distributed into
three groups according to the coronary artery remodeling
attained; there were no significant differences in baseline
clinical characteristics among the three remodeling groups.
Similarly, the lesion morphology and diameters, lengths and
types of implanted stents were comparable among the three
groups.
The QCA results are summarized in Table 2. At baseline
and immediately after stenting, there were no differences in
the reference diameter, minimal luminal diameter or diam-
eter stenosis among the three remodeling groups. At follow-
up, the inadequate remodeling group had significantly larger
minimal luminal diameter than the adequate remodeling
group (p , 0.05). Angiographic restenosis was more frequently
observed in the adequate remodeling group than in the
inadequate remodeling group (28.8% and 9.4%, respectively).
IVUS results. Table 3 shows the overall quantitative IVUS
results in each arterial remodeling group. Among the three
remodeling groups, no significant differences were seen in
the minimal lumen CSA, the proximal and distal reference
EEM CSA at preintervention, or in the minimal stent CSA
immediately after the intervention. The adequate
remodeling group had significantly larger EEM CSA and
plaque CSA at the site of the minimal lumen CSA before
the intervention than the intermediate and inadequate
remodeling groups. At follow-up, the minimal lumen CSA
was smaller, and the intimal hyperplasia CSA was larger in
the adequate remodeling group than in the inadequate
remodeling group (p , 0.01 and p , 0.01, respectively),
though no significant difference was found in the stent
CSA.
Correlation among plaque burden, remodeling and inti-
mal hyperplasia. Correlation between preinterventional
plaque CSA and in-stent intimal hyperplasia CSA is shown
in Figure 1. A significant positive correlation was found
between preinterventional plaque CSA and intimal hyper-
plasia CSA at follow-up (r 5 0.47, p , 0.0001). Moreover,
the remodeling index significantly correlated with the rela-
tive intimal hyperplasia CSA (r 5 0.28, p , 0.01). Multiple
regression analysis revealed that both plaque burden and
types of arterial remodeling were significant independent
variables for predicting intimal hyperplasia CSA (p , 0.001
and p , 0.05, respectively).
DISCUSSION
The main findings in this study were that preinterventional
plaque CSA and the degree of intimal hyperplasia after
stenting were significantly larger in the adequate remodeling
group than in the inadequate remodeling group. Moreover,
both preinterventional plaque burden and remodeling index
correlated with the extent of in-stent neointimal hyperplasia.
Table 1. Clinical Characteristics, Lesion Morphology and Stent Form
Adequate
(n 5 52)
Intermediate
(n 5 29)
Inadequate
(n 5 32)
p Value
(ANOVA)
Men/Women 42/10 23/6 23/9 NS
Age (yrs) 63.3 6 9.5 62.4 6 8.2 63.8 6 6.9 NS
DM (%) 13 (25%) 8 (28%) 9 (28%) NS
HT (%) 29 (56%) 11 (38%) 16 (50%) NS
HL (%) 34 (65%) 17 (59%) 24 (75%) NS
Type B2/C (%) 24 (46%) 11 (38%) 15 (47%) NS
Stent diameter (mm) 3.3 6 0.3 3.3 6 0.3 3.4 6 0.3 NS
Stent length (mm) 14.0 6 1.7 14.2 6 1.5 14.1 6 1.4 NS
PS/ML 26/26 14/15 18/14 NS
DM 5 diabetes mellitus; HT 5 hypertension; HL 5 hyperlipidemia; Type B2/C 5 type B2 or C lesions according to the
ACC/AHA classification; PS 5 group of arteries that used the Palmaz-Schatz stent; ML 5 group of arteries that used the
Multi-Link stent; NS 5 not significant.
Table 2. Quantitative Coronary Angiographic Results
Adequate
(n 5 52)
Intermediate
(n 5 29)
Inadequate
(n 5 32)
p Value
(ANOVA)
Preintervention
Reference diameter (mm) 3.1 6 0.9 3.0 6 0.6 3.0 6 0.7 NS
Minimal luminal diameter (mm) 1.0 6 0.4 1.1 6 0.6 1.1 6 0.4 NS
Diameter stenosis (%) 67.3 6 11.9 63.3 6 15.9 63.9 6 14.3 NS
Immediately after intervention
Minimal luminal diameter (mm) 3.1 6 0.6 3.2 6 0.5 3.1 6 0.4 NS
Diameter stenosis (%) 10.5 6 7.8 8.4 6 7.0 10.4 6 8.0 NS
Follow-up
Minimal luminal diameter (mm) 2.0 6 0.8* 1.9 6 0.6† 2.4 6 0.7 , 0.01
Diameter stenosis (%) 35.6 6 22.1* 33.4 6 22.1 24.2 6 14.8 , 0.05
*p , 0.05 vs. inadequate remodeling group; †p , 0.01 vs. inadequate remodeling group; NS 5 not significant.
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Remodeling and coronary stenosis. It had been believed
that the luminal narrowing of arteries in patients with
coronary artery disease depended mainly on the accumula-
tion of atherosclerotic plaques along the arterial wall.
However, based on the results of histopathological (6) and
IVUS studies (7–9), the degree of arterial remodeling,
which occurs to compensate for the accumulation of plaque,
contributed to the narrowing of the lumen at the athero-
sclerotic lesion. Glagov et al. (6) revealed that compensatory
arterial enlargement prevented the luminal area from en-
croachment by the expanding plaque in the early stages of
atherosclerosis; but when plaque expansion progressed,
occupying $40% of the EEM CSA, this protective mech-
anism failed to compensate for further increases of plaque
mass, and the luminal area decreased. Inadequate arterial
enlargement was observed in some of the atherosclerotic
Table 3. Quantitative Intravascular Ultrasound Results
Adequate
(n 5 52)
Intermediate
(n 5 29)
Inadequate
(n 5 32)
p Value
(ANOVA)
Preintervention
Lesion site
EEM CSA (mm2) 18.0 6 5.0 13.7 6 3.4† 12.7 6 4.1† , 0.01
Lumen CSA (mm2) 2.4 6 0.8 2.3 6 1.0 2.4 6 1.1 NS
Plaque CSA (mm2) 15.7 6 4.8 11.3 6 3.3† 10.3 6 3.8† , 0.01
Plaque index (%) 86.0 6 5.3 82.5 6 6.6* 79.8 6 8.8† , 0.01
Reference site
Proximal EEM CSA
(mm2)
17.3 6 5.1 16.5 6 4.1 18.4 6 4.8 NS
Distal EEM CSA (mm2) 13.5 6 4.8 12.3 6 3.4 14.8 6 4.8 NS
Immediately after intervention
Minimal stent CSA (mm) 10.1 6 3.3 9.7 6 2.7 10.4 6 2.9 NS
Follow-up
Lumen CSA (mm2) 4.9 6 2.3 5.3 6 2.2 6.6 6 3.2† , 0.05
Stent CSA (mm2) 9.8 6 2.9 9.2 6 2.5 10.2 6 3.4 NS
IH CSA (mm2) 5.0 6 2.5 3.8 6 2.0* 3.6 6 2.7† , 0.05
Relative IH CSA (%) 50.7 6 19.3 41.5 6 18.3 35.2 6 20.1† , 0.01
*p , 0.05 vs. adequate remodeling group; †p , 0.01 vs. adequate remodeling group; NS 5 not significant
EEM 5 external elastic membrane; CSA 5 cross-sectional area; plaque index 5 (plaque CSA/EEM CSA) 3 100; IH 5
intimal hyperplasia; relative IH CSA 5 (IH CSA/Stent CSA) 3 100.
Figure 1. Correlation between preinterventional lesion site plaque cross-sectional area and in-stent intimal hyperplasia.
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coronary arteries (10,11), and it might contribute to the
progression of luminal narrowing by shrinking the EEM.
Thus, the development of coronary stenosis would be closely
related to the degree of arterial remodeling.
Remodeling and intimal hyperplasia. The mechanisms of
restenosis in stented lesions differ from those in nonstented
lesions (13–16). In nonstented lesions, late constriction of
the EEM CSA after angioplasty appeared to play a more
significant role in causing restenosis than did neointimal
proliferation. On the other hand, in stented lesions, stents
prevented the remodeling process of late vessel-constriction,
and restenosis was the result of uniform neointimal tissue
proliferation throughout the stent (17,18). Therefore, it is
important to suppress in-stent neointimal hyperplasia.
Predictors for in-stent restenosis were reported, including
1) longer stented segment, 2) reference vessel diameter, 3)
percent diameter stenosis after stenting, 4) preinterventional
plaque burden at the lesion site, 5) final luminal area, and 6)
residual plaque burden outside the stent (19–21). In our
study, no differences were seen in reference diameter,
reference EEM CSA, and minimal lumen CSA at prein-
tervention, or in the QCA and IVUS results immediately
after stenting among the groups. However, the adequate
remodeling group had a significantly larger restenosis rate,
neointimal hyperplasia CSA and preinterventional plaque
CSA at the lesion site than did the inadequate remodeling
group.
Furthermore, the preinterventional plaque CSA at the
lesion site correlated with the amount of in-stent neointimal
hyperplasia at follow-up. Thus, the larger the preinterven-
tional plaque burden is, the severer the degree of neointimal
hyperplasia is. The underlying mechanism by which plaque
burden is related to neointimal hyperplasia remains to be
elucidated, but deep vessel injury might be aggravated in
proportion to the amount of plaque burden because the
stretching force needed to expand the vessel is proportionate
to the vessel wall resistance manifested by the amount of the
plaque burden (22). Carter et al. (23) demonstrated the
correlation between neointimal hyperplasia and the extent
of plaque or medial compression by the stent. Their exper-
imental study with rabbits might support the hypothesis.
Remodeling and atherectomy before stenting. Moussa et
al. (22) evaluated 62 patients with 75 lesions who underwent
directional coronary atherectomy before stenting and angio-
graphic evaluation 5.7 months after stenting. They con-
cluded that plaque removal by directional coronary atherec-
tomy before stenting might reduce angiographic restenosis
and the need for repeated coronary interventions. However,
it remains unclear whether we should always remove plaque
by atherectomy, because aggressive atherectomy could result
in an increased incidence of complications. We clearly
demonstrated that the restenosis rate of stenting for the
lesions with inadequate arterial remodeling was very low
(9.4%) by comparison with adequate remodeling (28.8%).
This result is comparable to the previous report in which the
restenosis rate of stenting after optimal lesion debulking was
11% (22). In addition, in the atherosclerotic lesions with
inadequate arterial remodeling, plaque burden at the lesion
site may be less than that at the reference site (11). When
the target lesion shows adequate arterial remodeling and the
plaque burden is large, atherectomy before stenting might
be a useful procedure for suppressing the development of
in-stent neointimal hyperplasia and restenosis. Conversely,
when the target lesion shows inadequate arterial remodel-
ing, plaque removal before stenting might be unnecessary.
However, we have no data to support this hypothesis. It
should be verified by a randomized study that compares
lesions with adequate remodeling, subjected to plaque de-
bulking before stenting, with their negative controls.
Study limitations. To evaluate the relation between the
degree of preinterventional arterial remodeling and in-stent
neointimal hyperplasia, we excluded the lesions where
pretreatment with an atheroablative device was performed
before stenting. Moreover, the small number of study
patients did not allow comparison between the lesions
subjected to plaque debulking before stenting and those
subjected to stenting alone, within the group of lesions
showing adequate arterial remodeling.
Conclusions. Our data revealed that preinterventional ar-
terial remodeling influenced the development of intimal
hyperplasia after stenting and that preinterventional plaque
burden and remodeling index correlated with the extent of
in-stent neointimal hyperplasia.
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